Chemotherapy News and Research

Latest Chemotherapy News and Research

Chapman University's School of Pharmacy wins more than $3.5 million through 30 research awards

Chapman University’s four-year-old School of Pharmacy continues its aggressive growth in federal grant awards.

16 Aug 2017

Researchers identify new factors that may affect brain tumor cells' ability to resist treatment

The most aggressive variant of brain tumor - glioblastoma - has an average survival rate of 15 months. There is therefore an urgent need for new treatment strategies for this group of patients.

16 Aug 2017

Cancer treatment with alternative medicine can double risk of dying: Study finds

A new study has found that patients who choose cancer treatment with alternative medicine more than double the risk of dying in five years compared to those who chose conventional cancer treatment for the treatable cancers. The study is published in the Journal of the National Cancer Institute.

15 Aug 2017

Climbing cost of decades-old drugs threatens to break Medicaid bank

Skyrocketing price tags for new drugs to treat rare diseases have stoked outrage nationwide. But hundreds of old, commonly used drugs cost the Medicaid program billions of extra dollars in 2016 vs. 2015, a Kaiser Health News data analysis shows.

14 Aug 2017

Alternative medicine use instead of proven cancer therapies results in worse survival

Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death, according to researchers from the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine and Yale Cancer Center.

11 Aug 2017

Colorectal cancer deaths on the rise among Americans: JAMA study

A new study from the American Cancer Society has found that more people living in the United States of America are dying from colon and rectal cancers around the age of 50 years when they are supposed to officially begin screening for these cancers. The new study is published in the JAMA, the Journal of the American Medical Association.

10 Aug 2017

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Investigators at Children's Hospital Los Angeles have succeeded in better defining a rare pediatric malignant liver disease -- a necessary step in achieving an optimum treatment.

9 Aug 2017

Researchers find racial and gender disparities in survival of patients with anal cancer

Over the past 30 years, squamous cell carcinoma of the anus (SCCA) is one of the few cancers with steadily rising incidence in the United States, with the most rapid increase seen in black men.

9 Aug 2017

NYITCOM research could potentially lead to more effective, less toxic cancer treatment

Patients undergoing conventional chemotherapy for certain cancers could potentially receive more effective and less toxic drug treatment.

9 Aug 2017

Researchers find clues to how chemotherapy drug fuels cancer spread from the breast to lungs

The very same treatment that thwarts breast cancer has a dark side – it can fuel the spread of the disease to the lungs.

8 Aug 2017

Gold shines bright in cancer therapy research: New Edinburgh University study

According to latest research, gold particles can be effective in certain cancer therapy areas. Researchers at the Edinburgh University report in their new study that gold particles can help enhance the effectiveness of the agents used for lung cancer cells. The study is published in the scientific journal Angewandte Chemie.

8 Aug 2017

Bioactive 'tissue papers' show potential for regenerative medicine

Northwestern Medicine scientists and engineers have invented a range of bioactive "tissue papers" made of materials derived from organs that are thin and flexible enough to even fold into an origami bird.

7 Aug 2017

Tiny medical device containing gold specks could boost effects of cancer drugs

A tiny medical device containing gold specks could boost the effects of cancer medication and reduce its harm, research suggests.

7 Aug 2017

Researchers find higher proportion of aggressive breast cancer subtypes in black women

A higher proportion of aggressive breast cancer subtypes are seen in black women, University of North Carolina Lineberger Comprehensive Cancer Center researchers have found.

4 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

Researchers deliver knock-out blow to different types of cancer

Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease, according to research funded by Cancer Research UK and published in the Journal of the National Cancer Institute today (Thursday).

3 Aug 2017

UCLA research in sarcoma provides much-needed roadmap for personalizing therapies

Sarcoma is a rare and deadly form of cancer occurring in the bones and connective tissue that affects individuals of all ages.

3 Aug 2017

Vanderbilt researchers unravel how bacterial toxin prevents DNA replication

One of the most potent toxins known acts by welding the two strands of the famous double helix together in a unique fashion which foils the standard repair mechanisms cells use to protect their DNA.

2 Aug 2017

Shaping the future of oncology treatment

Victories Over Cancer is about enabling those affected by cancer to enjoy more of life’s meaning full moments and making cancer more manageable. At Janssen, we're really thinking about the elimination of cancer, and we take a very deliberate approach to that.

2 Aug 2017

$New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod$

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

The U.S. Food and Drug Administration (FDA) in a statement yesterday reported its approval for a new drug, Idhifa (enasidenib) for the treatment of acute myeloid leukemia (AML) in adults that has either relapsed or is refractory to standard chemotherapy.

2 Aug 2017

Chemotherapy News and Research

Latest Chemotherapy News and Research

Chapman University's School of Pharmacy wins more than $3.5 million through 30 research awards

Researchers identify new factors that may affect brain tumor cells' ability to resist treatment

Cancer treatment with alternative medicine can double risk of dying: Study finds

Climbing cost of decades-old drugs threatens to break Medicaid bank

Alternative medicine use instead of proven cancer therapies results in worse survival

Colorectal cancer deaths on the rise among Americans: JAMA study

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Researchers find racial and gender disparities in survival of patients with anal cancer

NYITCOM research could potentially lead to more effective, less toxic cancer treatment

Researchers find clues to how chemotherapy drug fuels cancer spread from the breast to lungs

Gold shines bright in cancer therapy research: New Edinburgh University study

Bioactive 'tissue papers' show potential for regenerative medicine

Tiny medical device containing gold specks could boost effects of cancer drugs

Researchers find higher proportion of aggressive breast cancer subtypes in black women

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

Researchers deliver knock-out blow to different types of cancer

UCLA research in sarcoma provides much-needed roadmap for personalizing therapies

Vanderbilt researchers unravel how bacterial toxin prevents DNA replication

Shaping the future of oncology treatment

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in